Risk assessment models have identified that nearly two-thirds of U.S. adults over the age of 20 are at risk of developing CKD at some point in their life. Within that population, specific high-risk groups have emerged such as diabetics, hypertensives, and those with a family history of chronic disease.
Screening of high risk individuals, along with subsequent confirmation of diagnosis and monitoring of the diagnosed, can be accomplished in a structured, financially feasible plan with the right biomarkers being utilized at the correct time in the continuum of disease.
Robert H. Christenson, PhD, DABCC, FACB
Professor of Pathology and Professor of Medical and Research Technology
University of Maryland School of Medicine